Follistatin 344 Odin Pharma 10 x 10iu Odin Pharmaceuticals

£132.00

Follistatin 344 is a research peptide that acts as a myostatin inhibitor, studied for muscle development and cellular signalling pathways in laboratory models. This 10-vial kit delivers precisely measured doses for controlled research protocols.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Follistatin 344 Odin Pharma 10 x 10iu Odin Pharmaceuticals
Follistatin 344 Odin Pharma 10 x 10iu Odin Pharmaceuticals
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: Follistatin 344 Odin Pharma 10 x

Follistatin 344 is a myostatin-binding protein studied extensively in muscle biology research applications. This glycoprotein naturally occurs in various tissues and demonstrates significant binding affinity to members of the TGF-β superfamily, particularly myostatin and activin. Scientists at Stroid UK Shop investigate how follistatin modulates muscle growth signalling cascades through its antagonistic effects on these growth factors.

The 344 amino acid variant represents the most abundant circulating form, distinguished from shorter isoforms by its extended C-terminal domain. Research models demonstrate that follistatin 344 exhibits enhanced stability and prolonged half-life compared to truncated variants. In cellular studies, this peptide demonstrates capacity to neutralise myostatin activity, potentially releasing the inhibitory constraints on muscle satellite cell proliferation and differentiation pathways.

Laboratory Applications

Research scientists examine follistatin 344 across diverse experimental protocols investigating muscle wasting conditions, metabolic dysfunction, and tissue regeneration models. Cell culture studies evaluate how this peptide influences myoblast proliferation rates and differentiation markers when co-cultured with various growth factors. Animal model research explores the systemic effects of follistatin administration on muscle mass preservation during immobilisation or disease-induced cachexia.

Investigators studying follistatin peptide mechanisms frequently combine this compound with other research molecules available through our peptides collection or SARMs inventory to examine synergistic pathway interactions. Published studies indicate potential applications in regenerative medicine research, where follistatin’s wound healing properties complement its muscle-specific effects.

Technical Specifications

Follistatin 344 Research Specifications
Parameter Value
Amino Acid Sequence Length 344 residues
Molecular Weight ~37.8 kDa
Storage Temperature -20°C (lyophilised)
Reconstitution Sterile bacteriostatic water
Package Configuration 10 vials × 10iu
Manufacturer Odin Pharmaceuticals
Research Grade Laboratory standard
CAS Number Verify with supplier

Research Compliance Statement

This follistatin 344 product is manufactured exclusively for in-vitro research purposes and laboratory analysis applications. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory protocols and safety measures when handling this research compound. All studies should comply with institutional guidelines and regulatory requirements for peptide research materials.

Related